| Literature DB >> 26835230 |
Fa Fang1, Jie Gao2, Xing Bi3, Feng Han4, Hai-Jiang Wang1.
Abstract
This study discusses the effect and clinical significance of fast-track surgery (FTS) combined with laparoscopic radical surgery on the plasma level of vascular endothelial growth factor (VEGF) in locally advanced gastric antrum cancer. Plasma VEGF levels were detected in 63 cases of locally advanced gastric antrum cancer by using double-antibody sandwich Avidinbiotincomplex-ELISA before and after operation. The pure laparoscopic surgery group (group A) comprised 30 cases, and the combined FTS group (group B) consisted of 33 cases. Results of the two groups were obtained at similar time points and then compared. The VEGF levels were not significantly different between the two groups on the first day before the operation and on the first day, third day, and sixth month after the operation (P > 0.05). However, the differences were significant on the seventh day and first month after the operation (P < 0.05). The postoperative eating time, anal exhaust time, and hospital stay of the patients were statistically significantly different between the two groups (P < 0.05). Nevertheless, no significant differences were detected in terms of wound healing time and complications (P > 0.05). The 3-year survival rate significantly differed between the two groups (P < 0.05). FTS combined with laparoscopic surgery can decrease the postoperative VEGF level compared with pure laparoscopic surgery. The combined approach improved postoperative recovery without prolonging the wound healing time or increasing the incidence of postoperative complications. The 3-year survival rate also increased. Thus, FTS combined with laparoscopic surgery can improve the prognosis in gastric antrum cancer.Entities:
Keywords: Fast-track surgery; Gastric antrum cancer; Laparoscopy; Survival rate; Vascular endothelial growth factor
Year: 2016 PMID: 26835230 PMCID: PMC4720622 DOI: 10.1186/s40064-016-1699-2
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
General clinical data of the two groups of patients with gastric antrum cancer
| Item | Group A | Group B |
|
|---|---|---|---|
| Sex (male/female) | 16/14 | 15/18 | 0.53 |
| Age (years) | 61.53 ± 12.37 | 61.12 ± 12.46 | 0.83 |
| Ethnic (Han/minority) | 27/3 | 29/4 | 0.79 |
| Preoperative complication (yes/no) | 13/17 | 14/19 | 0.94 |
| Surgical approach (Billorth I/Billorth II) | 12/18 | 17/16 | 0.36 |
| Pathological type | |||
| Mucinous adenocarcinoma, signet ring cell carcinoma and undifferentiated adenocarcinoma | 11 | 13 | 0.82 |
| Highly/moderately differentiated adenocarcinoma | 19 | 20 | |
| Type of tumor (protruded type/ulcerative type) | 14/16 | 12/21 | 0.41 |
Postoperative conditions of the two groups of patients
| Item | Group A | Group B |
|
|---|---|---|---|
| Operation time (min) | 253.20 ± 85.09 | 252.91 ± 84.92 | 1.00 |
| Intraoperative bleeding volume (ml)a | 211 | 205 | 1.00 |
| Perioperative blood transfusion (case) | 1/29 | 1/32 | 0.95 |
| Time of first anal exhaust (days) | 4.0 ± 1.0 | 2.5 ± 0.5 | 0.03 |
| Time for wound healing (days) | 10.0 ± 1.0 | 11.5 ± 1.5 | 0.29 |
| Postoperative eating time (days) | 4.5 ± 1.0 | 2.0 ± 0.5 | 0.02 |
| Postoperative complication (yes/no) | 2/28 | 2/31 | 0.92 |
| Postoperative hospital stay (days) | 18.5 ± 5.5 | 11.0 ± 2.0 | 0.00 |
| pT1–2/pT3 | 9/21 | 11/22 | 0.78 |
| pN0–1/pN2 | 14/16 | 18/15 | 0.53 |
aMedian for skewedly distributed data
Comparison of VEGF levels of the two groups before and after operation (X ± S) pg/ml
| Item | Group A | Group B |
|
|---|---|---|---|
| Day 1 before operation | 47.27 ± 34.17 | 47.51 ± 33.76 | 1.00 |
| Day 1 after operation | 54.38 ± 24.81 | 53.27 ± 23.96 | 0.94 |
| Day 3 after operation | 62.73 ± 25.13 | 59.18 ± 24.89 | 0.86 |
| Day 7 after operation | 79.93 ± 27.36 | 64.36 ± 28.14 | 0.04 |
| 1 month after operation | 47.28 ± 28.15 | 36.67 ± 25.12 | 0.03 |
| 6 months after operation | 36.32 ± 25.31 | 35.4 8 ± 24.95 | 0.85 |
Fig. 1Three-year survival curves of the two groups